Innovation in Every Vision.
At R2 Trading AI, we believe that perfect vision should not be a luxury, but a standard accessible through the power of advanced technology. Our mission is to bridge the gap between traditional ophthalmology and the digital future.
Founded by a collaborative team of leading medical doctors and visionary tech entrepreneurs, we've spent years researching the intersection of optical science and machine learning. Our platform isn't just about lenses; it's about a smarter, faster, and more precise way to understand your eyes.
By leveraging proprietary AI diagnostics, we eliminate the guesswork in prescription data, ensuring every user receives a tailored vision solution that fits their unique lifestyle — from the digital workspace to the great outdoors.
Trusted by the World's Leading Lens Manufacturers
We work directly with global industry leaders to deliver premium contact lens solutions powered by AI diagnostics.
Frequently Asked Questions
Our proprietary AI models are trained on 50,000+ successful prescriptions, achieving 99.2% diagnostic accuracy. We combine real-time topography analysis with partnerships from the world's top lens manufacturers.
Our first-fit success rate exceeds 90%, with an overall diagnostic accuracy of 99.2%. Each recommendation is cross-validated against clinical data from Johnson & Johnson Vision, Alcon, Bausch+Lomb, and CooperVision.
Absolutely. All data is processed with end-to-end encryption and stored in GDPR-compliant infrastructure. We never share personal health data with third parties.
R2 Trading AI currently operates in over 15 countries across Europe, the Middle East, and North America. We're expanding to additional markets in 2026.